[Federal Register: June 16, 2004 (Volume 69, Number 115)]
[Notices]
[Page 33635-33638]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16jn04-49]
[[Page 33635]]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[OPP-2004-0087; FRL-7350-6]
Clothianidin; Notice of Filing a Pesticide Petition to Establish
a Tolerance for a Certain Pesticide Chemical in or on Food
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the initial filing of a pesticide
petition proposing the establishment of regulations for residues of a
certain pesticide chemical in or on various food commodities.
DATES: Comments identified by docket identification (ID) number OPP-
2004-0087, must be received on or before July 16, 2004.
ADDRESSES: Comments may be submitted electronically, by mail, or
through hand delivery/courier. Follow the detailed instructions as
provided in Unit I. of the SUPPLEMENTARY INFORMATION.
FOR FURTHER INFORMATION CONTACT: Stephanie Nguyen, Registration
Division (7505C), Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-
0001; telephone number: (703) 605-0702; e-mail address:
nguyen.stephanie@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this Action Apply to Me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
Potentially affected entities may include, but are not limited to:
Crop production (NAICS 111)
Animal production (NAICS 112)
Food manufacturing (NAICS 311)
Pesticide manufacturing (NAICS 32532)
This listing is not intended to be exhaustive, but rather provides
a guide for readers regarding entities likely to be affected by this
action. Other types of entities not listed in this unit could also be
affected. The North American Industrial Classification System (NAICS)
codes have been provided to assist you and others in determining
whether this action might apply to certain entities. If you have any
questions regarding the applicability of this action to a particular
entity, consult the person listed under FOR FURTHER INFORMATION
CONTACT.
B. How Can I Get Copies of this Document and Other Related Information?
1. Docket. EPA has established an official public docket for this
action under docket ID number OPP-2004-0087. The official public docket
consists of the documents specifically referenced in this action, any
public comments received, and other information related to this action.
Although a part of the official docket, the public docket does not
include Confidential Business Information (CBI) or other information
whose disclosure is restricted by statute. The official public docket
is the collection of materials that is available for public viewing at
the Public Information and Records Integrity Branch (PIRIB), Rm. 119,
Crystal Mall 2, 1921 Jefferson Davis Hwy., Arlington, VA. This
docket facility is open from 8:30 a.m. to 4 p.m., Monday through
Friday, excluding legal holidays. The docket telephone number is (703)
305-5805.
2. Electronic access. You may access this Federal Register document
electronically through the EPA Internet under the ``Federal Register''
listings at http://www.epa.gov/fedrgstr/.
An electronic version of the public docket is available through
EPA's electronic public docket and comment system, EPA Dockets. You may
use EPA Dockets at http://www.epa.gov/edocket/ to submit or view public
comments, access the index listing of the contents of the official
public docket, and to access those documents in the public docket that
areavailable electronically. Although not all docket materials may be
available electronically, you may still access any of the publicly
available docket materials through the docket facility identified in
Unit I.B.1. Once in the system, select ``search,'' then key in the
appropriate docket ID number.
Certain types of information will not be placed in EPA's Dockets.
Information claimed as CBI and other information whose disclosure is
restricted by statute, which is not included in the official public
docket, will not be available for public viewing in EPA's electronic
public docket. EPA's policy is that copyrighted material will not be
placed in EPA's electronic public docket but will be available only in
printed, paper form in the official public docket. To the extent
feasible, publicly available docket materials will be made available in
EPA's electronic public docket. When a document is selected from the
index list in EPA Dockets, the system will identify whether the
document is available for viewing in EPA's electronic public docket.
Although not all docket materials may be available electronically, you
may still access any of the publicly available docket materials through
the docket facility identified in Unit I.B. EPA intends to work towards
providing electronic access to all of the publicly available docket
materials through EPA's electronic public docket.
For public commenters, it is important to note that EPA's policy is
that public comments, whether submitted electronically or in paper,
will be made available for public viewing in EPA's electronic public
docket as EPA receives them and without change, unless the comment
contains copyrighted material, CBI, or other information whose
disclosure is restricted by statute. When EPAidentifies a comment
containing copyrighted material, EPA will provide a reference to that
material in the version of the comment that is placed in EPA's
electronic public docket. The entire printed comment, including the
copyrighted material, will be available in the public docket.
Public comments submitted on computer disks that are mailed or
delivered to the docket will be transferred to EPA's electronic public
docket. Public comments that are mailed or delivered to the docket will
be scanned and placed in EPA's electronic public docket. Where
practical, physical objects will be photographed, and the photograph
will be placed in EPA's electronic public docket along with a brief
description written by the docket staff.
C. How and to Whom Do I Submit Comments?
You may submit comments electronically, by mail, or through hand
delivery/courier. To ensure proper receipt by EPA, identify the
appropriate docket ID number in the subject line on the first page of
your comment. Please ensure that your comments are submitted within the
specified comment period. Comments received after the close of the
comment period will be marked ``late.'' EPA is not required to consider
these late comments. If you wish to submit CBI or information that is
otherwise protected by statute, please follow the instructions in Unit
I.D. Do not use EPA Dockets or e-mail to submit CBI or information
protected by statute.
1. Electronically. If you submit an electronic comment as
prescribed in this unit, EPA recommends that you include your name,
mailing address, and an e-mail address or other contact information in
the body of your comment. Also include this contact information on the
outside of any disk
[[Page 33636]]
or CD ROM you submit, and in any cover letter accompanying the disk or
CD ROM. This ensures that you can be identified as the submitter of the
comment and allows EPA to contact you in case EPA cannot read your
comment due to technical difficulties or needs further information on
the substance of your comment. EPA's policy is that EPA will not edit
your comment, and any identifying or contact information provided in
the body of a comment will be included as part of the comment that is
placed in the official public docket, and made available in EPA's
electronic public docket. If EPA cannot read your comment due to
technical difficulties and cannot contact you for clarification, EPA
may not be able to consider your comment.
i. EPA Dockets. Your use of EPA's electronic public docket to
submit comments to EPA electronically is EPA's preferred method for
receiving comments. Go directly to EPA Dockets at http://www.epa.gov/edocket/
, and follow the online instructions for submitting comments.
Once in the system, select ``search,'' and then key in docket ID number
OPP-2004-0087. The system is an ``anonymous access'' system, which
means EPA will not know your identity, e-mail address, or other contact
information unless you provide it in the body of your comment.
ii. E-mail. Comments may be sent by e-mail to opp-docket@epa.gov,
Attention: Docket ID Number OPP-2004-0087. In contrast to EPA's
electronic public docket, EPA's e-mail system is not an ``anonymous
access'' system. If you send an e-mail comment directly to the docket
without going through EPA's electronic public docket, EPA's e-mail
system automatically captures your e-mail address. E-mail addresses
that are automatically captured by EPA's e-mail system are included as
part of the comment that is placed in the official public docket, and
made available in EPA's electronic public docket.
iii. Disk or CD ROM. You may submit comments on a disk or CD ROM
that you mail to the mailing address identified in Unit I.C.2. These
electronic submissions will be accepted in WordPerfect or ASCII file
format. Avoid the use of special characters and any form of encryption.
2. By mail. Send your comments to: Public Information and Records
Integrity Branch (PIRIB) (7502C), Office of Pesticide Programs (OPP),
Environmental Protection Agency, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460-0001, Attention: Docket ID Number OPP-2004-0087.
3. By hand delivery or courier. Deliver your comments to: Public
Information and Records Integrity Branch (PIRIB), Office of Pesticide
Programs (OPP), Environmental Protection Agency, Rm. 119, Crystal Mall
2, 1921 Jefferson Davis Hwy., Arlington, VA, Attention: Docket
ID Number OPP-2004-0087. Such deliveries are only accepted during the
docket's normal hours of operation as identified in Unit I.B.1.
D. How Should I Submit CBI to the Agency?
Do not submit information that you consider to be CBI
electronically through EPA's electronic public docket or by e-mail. You
may claim information that you submit to EPA as CBI by marking any part
or all of that information as CBI (if you submit CBI on disk or CD ROM,
mark the outside of the disk or CD ROM as CBI and then identify
electronically within the disk or CD ROM the specific information that
is CBI). Information so marked will not be disclosed except in
accordance with procedures set forth in 40 CFR part 2.
In addition to one complete version of the comment that includes
any information claimed as CBI, a copy of the comment that does not
contain the information claimed as CBI must be submitted for inclusion
in the public docket and EPA's electronic public docket. If you submit
the copy that does not contain CBI on disk or CD ROM, mark the outside
of the disk or CD ROM clearly that it does not contain CBI. Information
not marked as CBI will be included in the public docket and EPA's
electronic public docket without prior notice. If you have any
questions about CBI or the procedures for claiming CBI, please consult
the person listed under FOR FURTHER INFORMATION CONTACT.
E. What Should I Consider as I Prepare My Comments for EPA?
You may find the following suggestions helpful for preparing your
comments:
1. Explain your views as clearly as possible.
2. Describe any assumptions that you used.
3. Provide copies of any technical information and/or data you used
that support your views.
4. If you estimate potential burden or costs, explain how you
arrived at the estimate that you provide.
5. Provide specific examples to illustrate your concerns.
6. Make sure to submit your comments by the deadline in this
notice.
7. To ensure proper receipt by EPA, be sure to identify the docket
ID number assigned to this action in the subject line on the first page
of your response. You may also provide the name, date, and Federal
Register citation.
II. What Action is the Agency Taking?
EPA has received a pesticide petition as follows proposing the
establishment and/or amendment of regulations for residues of a certain
pesticide chemical in or on various food commodities under section 408
of the Federal Food, Drug, and Cosmetic Act (FFDCA), 21 U.S.C. 346a.
EPA has determined that this petition contains data or information
regarding the elements set forth in FFDCA section 408(d)(2); however,
EPA has not fully evaluated the sufficiency of the submitted data at
this time or whether the data support granting of the petition.
Additional data may be needed before EPA rules on the petition.
List of Subjects
Environmental protection, Agricultural commodities, Feed additives,
Food additives, Pesticides and pests, Reporting and recordkeeping
requirements.
Dated: May 27, 2004.
Lois Rossi,
Director, Registration Division, Office of Pesticide Programs.
Summary of Petition
The petitioner summary of the pesticide petition is printed below
as required by FFDCA section 408(d)(3). The summary of the petition was
prepared by the petitioner and represents the view of the petitioner.
The petition summary announces the availability of a description of the
analytical methods available to EPA for the detection and measurement
of the pesticide chemical residues or an explanation of why no such
method is needed.
Bayer CropScience
PP 3F6792
EPA has received a pesticide petition (3F6792) from Bayer
CropScience, 2 T.W. Alexander Drive, Research Triangle Park, NC 27709
proposing, pursuant to section 408(d) of the Federal Food, Drug, and
Cosmetic Act (FFDCA), 21 U.S.C. 346a(d), to amend 40 CFR part 180 by
establishing a tolerance for residues of clothianidin in or on the raw
agricultural commodities sorghum, grain at 0.01 part per million (ppm);
sorghum, forage at 0.01 ppm; and sorghum, stover at 0.01 ppm,
respectively. EPA has determined that the petition contains data or
information regarding the elements set forth in
[[Page 33637]]
section 408(d)(2) of the FFDCA; however, EPA has not fully evaluated
the sufficiency of the submitted data at this time or whether the data
support granting of the petition. Additional data may be needed before
EPA rules on the petition.
A. Residue Chemistry
1. Plant metabolism. In plants, the metabolism of clothianidin is
adequately understood for the purposes of establishing these proposed
tolerances. Unchanged parent clothianidin was the predominant residue
in all crop matrices (14.4% to 64.5% in corn, 66.1% to 96.6% in
tomatoes, 4.3% to 24.4% in sugar beets, and 24.3% to 63.3% in apples),
with the exception of sugar beet leaves. In sugar beet leaves, the main
components were the methylguanidine and thiazolylmethylguanidine
metabolites, accounting for 28.6% and 27.7%, respectively. All
metabolites found in plants were also found in the animal metabolism
studies. In animals, parent clothianidin was the major component in
liver, muscle, and fat. Based on the available metabolism data, parent
clothianidin, thiazolyl-guanidine (TZG), thiazolyl-urea (TZU), and
(ATMG-Pyr) aminothiazolyl methylguanidine-pyridine are proposed to be
considered as the residues of concern in livestock matrices.
2. Analytical method. In plants and plant products, the residue of
concern, parent clothianidin, can be determined using high performance
liquid chromotography (HPLC) with electrospray mass spectroscopy/mass
molecular size (MS/MS) detection. In an extraction efficiency testing,
the plant residues method has also demonstrated the ability to extract
aged clothianidin residue.
Although the plant residues lethal dose (LC)-MS/MS method is highly
suitable for enforcement method, an LC-ultraviolet (UV) method has also
been developed which is suitable for enforcement (monitoring) purposes
in all relevant matrices.
3. Magnitude of residues in sorghum. A total of 12 field trials was
conducted to evaluate the quantity of clothianidin in sorghum forage,
stover, and grain. Sorghum seed was treated with TI-435 600 fecal
streptococci (FS) at a rate of 250 grams active ingredient/100
kilograms (kg) seed. The highest average field trial was less than 0.01
ppm in sorghum forage, stover, and grain when collected at normal
harvest of 97 to 167 days after planting of treated seed. In a sorghum
processing study sorghum seed was treated at a 2X rate of 500 grams
active ingredient/100 kg seed. No residues at or above the limit of
quantitation (LOQ) of 0.01 ppm were found in the sorghum grain.
Therefore, a sorghum processing study was not conducted.
B. Toxicological Profile
1. Acute toxicity. The acute oral lethal dose (LD)50 was
>5,000 milligrams/kilogram/body weight (mg/kg/bwt) for both male and
female rats. The acute dermal LD50 was greater than 2,000
mg/kg/bwt in rats. The 4-hour inhalation LC50 was 5.538
miligrams/Liters (mg/L) for male and female rats. Clothianidin was not
irritating to rabbit skin and only slightly irritating to the eyes and
did not cause skin sensitization in guinea pigs.
2. Genotoxicity. Extensive mutagenicity studies were conducted with
clothianidin. Based on the weight of evidence clothianidin was
considered negative for genotoxicity.
3. Reproductive and developmental toxicity. In a 2-generation
reproduction study, rats were administered dietary levels of 0, 150,
500, and 2,500 ppm. The no observed effect level (NOAEL) for
reproductive parameters was 500 ppm (31.2/36.8 mg/kg/day; for male and
female), while the NOAEL for developmental effects was 150 ppm (9.8/
11.5 mg/kg/day; for male and female. The parental systemic NOAEL was
500 ppm (31.2/36.8 mg/kg/day; for male and female).
A developmental toxicity study was conducted in rats with
clothianidin using dose levels of 0, 10, 50, and 125 mg/kg/bwt by
gavage. The NOAEL for maternal toxicity was established at 10 mg/kg/bwt
and for developmental effects it was >125 mg/kg bwt. Additionally, a
developmental toxicity study was conducted with rabbits treated orally
by gavage at 0, 10, 25, 75, and 100 mg/kg/bwt. The NOAEL for maternal
toxicity was 25 mg/kg/bwt and for developmental toxicity it was 75 mg/
kg/bwt. Developmental toxicity studies showed no primary developmental
toxicity and no teratogenic potential was evident.
4. Subchronic toxicity. A 90-day feeding study was conducted in
rats and dogs. The rat study was conducted at dietary levels of 0, 150,
500, and 3,000 ppm and the dog study was conducted at 0, 325, 650, and
1,500 ppm. The NOAELs were established at 500 ppm (27.9/34.0 mg/kg/day;
for the male and female rat, and 650 ppm (19.3 mg/kg/day) for the male
dog, and 1,500 ppm (42.1 mg/kg/day) for the female dog.
5. Chronic toxicity. A 2-year combined rat chronic/oncogenicity
study conducted at dietary levels of 0, 150, 500, 1,500, and 3,000 ppm
demonstrated a NOAEL of 500 ppm (27.9/34.0 mg/kg/day) based on reduced
weight gains and non-neoplastic histomorphological changes. A 78-week
mouse oncogenicity study conducted at dose levels of 0, 100, 350,
1,250, and 2,000, and 1,800 ppm for males and females, respectively,
revealed a NOAEL of 350 ppm (47.2/65.1 mg/kg/day; for males and females
based on reduced body weight gains and increased incidence of
hypercellular hypertrophy. No evidence of oncogenicity was seen in the
rat or the mice. A 52-week chronic toxicity study in dogs conducted at
dietary levels of 0, 325, 650, 1,500, and 2,000 ppm revealed a NOAEL of
2,000 ppm (46.4 mg/kg/day) for the male dog and 1,500 ppm (40.1 mg/kg/
day) for the female dog.
6. Animal metabolism. The nature of the clothianidin residue in
livestock is adequately understood. In animals, parent clothianidin was
the major component in liver, muscle, and fat. Based on the available
metabolism data, parent clothianidin, TZG, TZU, and ATMG-Pyr are
proposed to be considered as the residues of concern in livestock
matrices.
7. Metabolite toxicology. Eight in vivo metabolites of clothianidin
identified in the rat were investigated for acute oral endpoint
mutagenic activity. None of the metabolites were mutagenic either with
or without activation and the LD50 values range from <500 to
>2,000 mg/kg, showing low to moderate toxicity.
8. Endocrine disruption. All guideline studies conducted to
characterize toxicological profile showed no endocrine related toxicity
or tumorgenicity. No effects on triiodothyronine (T3), throxine (T4),
or thyroid stimulating hormone (TSH) were observed in the subchronic
rat study. In a 2-generation reproduction study in rat; and rat and
rabbit teratology studies, clothianidin did not show reproductive or
teratogenic effects. The extensive data base shows that clothianidin
has no endocrine properties.
C. Aggregate Exposure
1. Dietary exposure. There are no residential uses for
clothianidin, therefore aggregate exposure consists of dietary (food
and drinking water) exposures. The acute population adjusted dose (PAD)
of 0.025 mg/kg bwt/day based on an acute NOAEL of 25 with an
uncertainty factor (UF) of 1,000 was used to assess acute dietary
exposure. The chronic (PAD) of 0.0098 mg/kg/bwt/day based on a chronic
NOAEL of 9.8 with an UF of 1,000 was used to assess chronic exposure.
i. Food. In the clothianidin pesticide tolerance action for corn
and canola, the
[[Page 33638]]
Federal Register notice of May 30, 2003 (68 FR 32390) (FRL-7306-8), EPA
conducted Tier I acute and chronic dietary assessments for
clothianidin. These assessments included residues of clothianidin that
arise from the uses of thiamethoxam which has clothianidin as a common
metabolite. Based on these assessments, a tolerance of 0.01 ppm for
sorghum use for clothianidin was added to the analysis. No significant
contribution was seen from this use. The U.S. population utilized 8.4%
(0.00211 mg/kg/bwt/day, 95\th\ percentile) of the acute PAD and 6.5%
(0.000635 mg/kg/bwt/day) of the chronic PAD. The most highly exposed
subpopulation is children 1 to 2 at 19.1% (0.004772 mg/kg/bwt/day,
95\th\ percentile) of the acute PAD and 19.1% (0.001874 mg/kg/bwt/day)
of the chronic PAD.
ii. Drinking water. EPA's Standard Operating Procedure (SOP) for
drinking water exposure and risk assessments was used to perform the
drinking water assessment. This SOP uses a variety of tools to conduct
drinking water assessment. These tools include water models such as
Screening Concentration in Groundwater (SCI-GROW), FQPA Index Reservoir
Screening Tool (FIRST), EPA's Pesticide Root Zone Model/Exposure
Analysis Modeling System (PRZM/EXAMS), and monitoring data. If
monitoring data are not available then the models are used to predict
potential residues in surface water and ground water and the highest is
assumed to be the drinking water residue. In the case of clothianidin,
monitoring data do not exist therefore SCI-GROW and FIRST were used to
estimate a water residue. The calculated drinking water levels of
comparison (DWLOC) for acute chronic exposure for all adults and
children exceed the drinking water estimated concentrations (DWEC) from
the models. The chronic DWLOC for adults is 321 parts per billion (ppb)
and the acute DWLOC is 801 ppb. The chronic DWLOC for children 1 to 2
is 79 ppb and the acute DWLOC is 202 ppb. The DWEC for the worst case
chronic scenario is 2.14 ppb FIRST and the acute DWEC FIRST is 3.97
ppb. The DWLOC are based on conservative dietary (food) exposures and
are expected to be much higher in real world situations.
2. Non-dietary exposure. Clothianidin products are not labeled for
residential uses (food or non-food), thereby eliminating the potential
for residential exposure or non-occupational exposure.
D. Cumulative Effects
Clothianidin is a metabolite of thiamethoxam. Therefore, residues
of clothianidin resulting from use of thiamethoxam were included in the
above risk assessment. There are no data available to indicate that
toxic effects produced by clothianidin are cumulative with those of any
other compound.
E. Safety Determination
1. U.S. population. Using the conservative exposure assumptions
described above and based on the completeness of the toxicity data, it
can be concluded that aggregate exposure to residues of clothianidin
present a reasonable certainty of no harm. Exposure from residues in
crops utilize 8.4% of the acute PAD and 6.5% of the chronic PAD. EPA
generally has no concerns for exposures below 100% of the PAD. DWLOC
are well above the estimated drinking water concentrations as
calculated by conservative models. There are no residential uses so
aggregate exposure consists of food and drinking water exposures. The
conservative Tier I assessments demonstrate a reasonable certainty of
no harm will result from uses of clothianidin for the U.S. population.
2. Infants and children. In assessing the potential for additional
sensitivity of infants and children to residues of clothianidin, the
data from developmental toxicity studies in both the rat and rabbit, a
2-generation reproduction study in rats and a developmental
neurotoxicity study in rats have been considered.
The developmental toxicity studies evaluate potential adverse
effects on the developing animal resulting from pesticide exposure of
the mother during prenatal development. The reproduction study
evaluates effects from exposure to the pesticide on the reproductive
capability of mating animals through 2-generations, as well as any
observed systemic toxicity.
The developmental neurotoxicity studies evaluate the
neurobehavioral and neurotoxic effects on the developing animal
resulting from the exposure of the mother. FFDCA section 408 provides
that EPA may apply an additional UF for infants and children based on
the threshold effects to account for prenatal and postnatal effects and
the completeness of the toxicity data base. Based on the current
toxicological data requirements the toxicology data base for
clothianidin relative to prenatal and postnatal development is
complete, including the developmental neurotoxicity study. None of the
studies indicated the offsprings to be more sensitive. All effects were
secondary to severe maternal toxicity. Therefore, no additional safety
or UF is justified.
F. International Tolerances
No CODEX maximum residue levels have been established for residues
of clothianidin on any crops at this time.
[FR Doc. 04-13411 Filed 6-15-04; 8:45 am]
BILLING CODE 6560-50-S